Longmaster Information & Technology Co., Ltd. (SHE:300288)
14.61
-0.12 (-0.81%)
Feb 13, 2026, 3:04 PM CST
SHE:300288 Revenue
Longmaster Information & Technology had revenue of 72.53M CNY in the quarter ending September 30, 2025, a decrease of -36.46%. This brings the company's revenue in the last twelve months to 305.26M, down -25.59% year-over-year. In the year 2024, Longmaster Information & Technology had annual revenue of 379.07M, down -17.52%.
Revenue (ttm)
305.26M
Revenue Growth
-25.59%
P/S Ratio
16.17
Revenue / Employee
376.86K
Employees
810
Market Cap
4.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 379.07M | -80.51M | -17.52% |
| Dec 31, 2023 | 459.58M | 22.97M | 5.26% |
| Jan 1, 2023 | 436.62M | 30.65M | 7.55% |
| Jan 1, 2022 | 405.97M | 30.73M | 8.19% |
| Dec 31, 2020 | 375.24M | -60.47M | -13.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| Realcan Pharmaceutical Group | 7.32B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.74B |
| Hefei Lifeon Pharmaceutical | 1.47B |
| Tibet Weixinkang Medicine | 1.17B |